BioVille is part of a bigger network:
Sector: Drone-industrie
Sector: Health & Care sector
Sector: Technologie- en servicessector
Sector: Creatieve en innovatieve business
Sector: Smart energy
Sector: Circulaire economie
Sector: Land- en tuinbouw
Rejuvenate Biomed Doses First Patient in Phase 2 Trial on COPD-related Muscle Weakness and Sarcopenia
Rejuvenate Biomed has dosed the first patient in a Phase 2 clinical trial evaluating the safety and efficacy of RJx-01 in older adults with COPD-related muscle weakness. This double-blind, placebo-controlled study, conducted in collaboration with the NIHR Leicester Biomedical Research Centre and Wellcome Leap, will assess 130 patients following hospitalization for severe COPD exacerbation. The trial aims to preserve muscle strength and physical function, thereby improving the quality of life for this vulnerable population. RJx-01 previously demonstrated positive outcomes in a Phase 1b study for sarcopenia.
